Cargando…
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
OBJECTIVE: Maternal embryonic leucine zipper kinase (MELK) is receiving an attention as a therapeutic target in various types of cancers. In this study, we aimed to evaluate the prognostic significance of MELK expression in ovarian cancer using clinical samples, and assessed the efficacy of a small...
Autores principales: | Ikeda, Yuji, Sato, Sho, Yabuno, Akira, Shintani, Daisuke, Ogasawara, Aiko, Miwa, Maiko, Zewde, Makda, Miyamoto, Takashi, Fujiwara, Keiichi, Nakamura, Yusuke, Hasegawa, Kosei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593222/ https://www.ncbi.nlm.nih.gov/pubmed/33078598 http://dx.doi.org/10.3802/jgo.2020.31.e93 |
Ejemplares similares
-
Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
por: Sato, Masakazu, et al.
Publicado: (2022) -
Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
por: Ogasawara, Aiko, et al.
Publicado: (2020) -
Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target
por: Makki Almansour, Nahlah
Publicado: (2022) -
Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
por: Nakano, Ichiro, et al.
Publicado: (2005) -
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2016)